Conversion Rate to Resectability in Colorectal Cancer Liver Metastases: Need for Criteria Adapted to Current Therapy.
Author(s): Timofeiov S, Marinca M, Camelia Bar, Mihaela Elena Breaban, Drug V and Scripcariu VTimofeiov S, Marinca M, Camelia Bar, Mihaela Elena Breaban, Drug V and Scripcariu V
Background: Therapeutic strategy for patients with colorectal cancer liver metastases (CRLM) is based on good monitoring and correct assignment to classes of liver resectability based on imaging criteria, taking into account the surgical risk. Objective: To identify the post-treatment time frame for confirming resectability (conversion to resecability) or permanent unresectability. Methods: The study is a prospective analysis based on a Scientific Protocol (Surveillance of patients with colorectal cancer liver metastases) used in the Ist Surgical Oncology Unit, Regional Institute of Oncology Ia?i, Romania. Surgical treatment, oncologic treatment, response to therapy , postoperative surgical complications, were assessed at 3, 6 and 9 months after start of the study. .. Read More»